The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

A new COVID-19 strain linked to a spike in cases in China has been detected in the U.S., but the CDC says it has seen so few cases that it has yet to be added to the agency's COVID Data Tracker ...

Doctors say there's no reason to believe the new variant will cause any more severe illness than previous mutations of the ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Since regaining power in January, the Trump administration has repeatedly claimed with false certainty that the COVID-19 ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

In India, the most common variant remains JN.1, comprising 53% of samples tested, followed by BA.2 (26%) and other Omicron ...